Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Cancer Research|April 19, 2007
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse modelQi Wu, Kaoru Kiguchi, Toru Kawamoto, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 3, 2017
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung CancerBoris Sepesi, Edwin Parra Cuentas, Jaime Rodriguez Canales, et al.
American Journal of Respiratory and Critical Care Medicine|September 9, 2008
Smoking-related genomic signatures in non-small cell lung cancerPierre P Massion, Yong Zou, Heidi Chen, et al.
Molecular Cancer Therapeutics|July 11, 2007
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasionAnne S Tsao, Dandan He, Babita Saigal, et al.
Head & Neck|December 18, 2018
PI3-kinase pathway biomarkers in oral cancer and tumor immune cellsMohammad Y Ibrahim, Maria I Nunez, Nusrat Harun, et al.
Annals of Diagnostic Pathology|April 22, 2014
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaAnne S Tsao, Nusrat Harun, Junya Fujimoto, et al.
Hepatology (Baltimore, Md.)|September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinomaFernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.
Development (Cambridge, England)|August 28, 2009
Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasisNili Jin, Sung-Nam Cho, M Gabriela Raso, et al.
Molecular Cancer Therapeutics|April 17, 2008
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-rasYanan Yang, Marie Wislez, Nobukazu Fujimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Cancer Research|April 19, 2007
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse modelQi Wu, Kaoru Kiguchi, Toru Kawamoto, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 3, 2017
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung CancerBoris Sepesi, Edwin Parra Cuentas, Jaime Rodriguez Canales, et al.
American Journal of Respiratory and Critical Care Medicine|September 9, 2008
Smoking-related genomic signatures in non-small cell lung cancerPierre P Massion, Yong Zou, Heidi Chen, et al.
Molecular Cancer Therapeutics|July 11, 2007
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasionAnne S Tsao, Dandan He, Babita Saigal, et al.
Head & Neck|December 18, 2018
PI3-kinase pathway biomarkers in oral cancer and tumor immune cellsMohammad Y Ibrahim, Maria I Nunez, Nusrat Harun, et al.
Annals of Diagnostic Pathology|April 22, 2014
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaAnne S Tsao, Nusrat Harun, Junya Fujimoto, et al.
Hepatology (Baltimore, Md.)|September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinomaFernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.
Development (Cambridge, England)|August 28, 2009
Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasisNili Jin, Sung-Nam Cho, M Gabriela Raso, et al.
Molecular Cancer Therapeutics|April 17, 2008
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-rasYanan Yang, Marie Wislez, Nobukazu Fujimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Pageof 13